⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL322605 | 0.93 | — | — | |
| Bicarbonate SCHEMBL9303198 | 0.89 | — | — | |
| SCHEMBL26173836 | 0.77 | MGLL (0.33) | — | |
| SCHEMBL706497 | 0.76 | — | — | |
| SCHEMBL45106 | 0.73 | — | — | |
| SCHEMBL4620757 | 0.73 | — | — | |
| SCHEMBL22635959 | 0.73 | — | — | |
| SCHEMBL2810989 | 0.72 | — | — | |
| SCHEMBL423792 | 0.72 | — | — | |
| SCHEMBL29406614 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414490-A1 | IMMUNOMODULATORY OLIGONUCLEOTIDE FORMULATIONS AND METHODS FOR USE THEREOF | Dynavax Technologies Corporation (US) | 2004-05-06 | — | — | EP | disclosed |
| WO-2003015816-A1 | IMMUNOMODULATORY OLIGONUCLEOTIDE FORMULATIONS AND METHODS FOR USE THEREOF | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2003-02-27 | — | — | WO | disclosed |